Efficacy of Four Different Treatment Regimes on Postpartum Hemorrhage: A Multicentric Randomized Controlled Trial
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Postpartum hemorrhage is the most important cause of maternal morbidity and mortality
worldwide and accounts for approximately 25% of deaths worldwide. Drugs such as oxytocin,
carbetocin and tranexamic acid are used for bleeding control after normal vaginal delivery.
The most widely used agent for the prevention of postpartum hemorrhage worldwide is oxytocin.
The primary aim of our study is to reduce the mean blood loss after vaginal delivery. In this
study, we aimed to compare the efficacy of carbetocin alone in the 1st group, oxytocin alone
in the 2nd group, carbetocin and tranexamic acid in the 3rd group, and oxytocin and
tranexamic acid in the 4th group in preventing postpartum blood loss originating from the
uterus.